SEARCH:   Advanced

Blood, 15 October 2005, Vol. 106, No. 8, pp. 2680-2687. Prepublished online as a Blood First Edition Paper on June 30, 2005; DOI 10.1182/blood-2004-12-4755. This Article Full Text (PDF) Supplemental Data All Versions of this Article: 2004-12-4755v1 106/8/2680    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Landry, J.-R. Articles by Gottgens, B. Search for Related Content PubMed PubMed Citation Articles by Landry, J.-R. Articles by Gottgens, B. Social Bookmarking                   What's this?  Previous Article  |  Next Article  Submitted December 16, 2004 Accepted June 6, 2005 Fli1, Elf1 and Ets1 regulate the proximal promoter of the LMO2 gene in endothelial cells Josette-Renee Landry, Sarah Kinston, Kathy Knezevic, Ian J Donaldson, Anthony R Green, and Berthold Gottgens* Department of Haematology, Cambridge Institute for Medical Research, Cambridge University, Cambridge, United Kingdom * Corresponding author; email: bg200{at}cam.ac.uk. Transcriptional control has been identified as a key mechanism regulating the formation and subsequent behaviour of haematopoietic stem cells. We have used a comparative genomics approach to identify transcriptional regulatory elements of the LMO2 gene, a transcriptional cofactor originally identified through its involvement in T-cell leukaemia and subsequently shown to be critical for normal haematopoietic and endothelial development. Of the two previously characterized LMO2 promoters, the second (proximal) promoter was highly conserved in vertebrates ranging from mammals to fish. Real-time RT-PCR expression analysis identified this promoter as the predominant source of transcription in haematopoietic tissue. Transient and stable transfections indicated that the proximal promoter was active in haematopoietic progenitor and endothelial cell lines and this activity was shown to depend on three conserved Ets sites which were bound in vivo by Elf1, Fli1 and Ets1. Finally, transgenic analysis demonstrated that the LMO2 proximal promoter is sufficient for expression in endothelial cells in vivo. No haematopoietic expression was observed indicating that additional enhancers are required to mediate transcription from the proximal promoter in haematopoietic cells. Together these results suggest that the conserved proximal promoter is central to LMO2 transcription in haematopoietic and endothelial cells, where it is regulated by Ets factors. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: W. Y. I. Chan, G. A. Follows, G. Lacaud, J. E. Pimanda, J.-R. Landry, S. Kinston, K. Knezevic, S. Piltz, I. J. Donaldson, L. Gambardella, et al. The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype Blood, March 1, 2007; 109(5): 1908 - 1916. [Abstract] [Full Text] [PDF]

	Blood Online is supported in part by Genentech BioOncology and Biogen Idec
	Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020